Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00982501 | WS®1442 in Slightly Overweight Subjects | PHASE1 | COMPLETED | 60 | — | — | Jun 1, 2008 | Feb 1, 2011 | May 14, 2014 | 1 | Austria |
| Arm | Type | Description |
|---|---|---|
| WS® 1442 900 mg | EXPERIMENTAL | - |
| WS® 1442 1800 mg | EXPERIMENTAL | - |
| Nordic walking training 2x30 min | ACTIVE_COMPARATOR | - |
| Nordic walking training 4x45 min | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| WS® 1442 900 mg/d | DRUG | - |
| WS® 1442 1800 mg/d | DRUG | - |
| Nordic walking training 2 x 30 min/week | BEHAVIORAL | - |
| Nordic walking training 4x45 min/week | BEHAVIORAL | - |
Inclusion Criteria: * written informed consent * male and female subjects aged 45-75 years * untrained * BMI between 25 and 29,9 kg/m² * resting blood pressure in sitting position ≤ 140/90 mmHg * inconspicuous ergometry Exclusion Criteria: * pregnancy or breastfeeding * any other current medicati...